Atlas Trials

GlaxoSmithKline

3,628 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch GlaxoSmithKline

RecordFirmDate
Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases (NCT00127023)GlaxoSmithKline2005-05-01
Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee (NCT00120900)GlaxoSmithKline2005-05-01
SB-681323-Methotrexate Interaction Study (NCT00419809)GlaxoSmithKline2005-05-01
A New Oral Treatment For Type II Diabetes Mellitus (NCT00111800)GlaxoSmithKline2005-04-28
Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancer (NCT00111787)GlaxoSmithKline2005-04-11
Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines (NCT00134719)GlaxoSmithKline2005-04-11
Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer (NCT00375765)GlaxoSmithKline2005-04-01
Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment (NCT00133848)GlaxoSmithKline2005-04-01
Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine (NCT00323622)GlaxoSmithKline2005-04-01
Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever) (NCT00348361)GlaxoSmithKline2005-04-01
Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action (NCT00118729)GlaxoSmithKline2005-04-01
Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray (NCT00109486)GlaxoSmithKline2005-04-01
Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo (NCT00133874)GlaxoSmithKline2005-04-01
SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C (NCT00110799)GlaxoSmithKline2005-04-01
Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate (NCT00327990)GlaxoSmithKline2005-04-01
A Study To Compare The Effects Of The Infusion Of A Sepsis Drug Between Healthy Adults And Adults With Damaged Livers (NCT00158769)GlaxoSmithKline2005-03-31
VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies. (NCT00116844)GlaxoSmithKline2005-03-29
Safety & Immunogenicity of 1 Dose of GSK134612 in Children 12-14 Months and 3-5 Years Old (NCT00196976)GlaxoSmithKline2005-03-24
A Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally to Subjects With Solid Tumors (NCT00742131)GlaxoSmithKline2005-03-17
A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa (NCT00263666)GlaxoSmithKline2005-03-16
Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast Cancer (NCT00140738)GlaxoSmithKline2005-03-10
Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine. (NCT00231413)GlaxoSmithKline2005-03-04
Evaluate 4 Different Formulations of Meningococcal Serogroups A, C, W-135, Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 15-19 Yrs (NCT00196963)GlaxoSmithKline2005-03-01
Seasonal Allergic Rhinitis In Pediatric Subjects (NCT00107757)GlaxoSmithKline2005-03-01
Spacer Comparison In Adult Asthmatics (NCT00369993)GlaxoSmithKline2005-03-01
Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects (NCT00144833)GlaxoSmithKline2005-03-01
Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response (NCT00197158)GlaxoSmithKline2005-03-01
Study of Immunological Memory Induced in Children by a Full 4 Dose Vaccination Schedule of 11 Valent Pneumococcal Conjugate Vaccine by Giving 1 Dose of Aventis Pasteur's 23-valent Pneumococcal Polysaccharide Vaccine (Pneumo 23) (NCT00169507)GlaxoSmithKline2005-03-01
Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer (NCT00316173)GlaxoSmithKline2005-03-01
Evaluation Of Valaciclovir In Patients With Chickenpox (NCT00169416)GlaxoSmithKline2005-03-01
Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197 (NCT00263653)GlaxoSmithKline2005-03-01
Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA (NCT00148928)GlaxoSmithKline2005-03-01
Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants (NCT00169455)GlaxoSmithKline2005-03-01
Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer (NCT00105950)GlaxoSmithKline2005-03-01
Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA) (NCT00169585)GlaxoSmithKline2005-03-01
Study of GW685698X In Patients With Seasonal Allergic Rhinitis (NCT00363740)GlaxoSmithKline2005-02-19
Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants (NCT00169442)GlaxoSmithKline2005-02-10
Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy (NCT00169572)GlaxoSmithKline2005-02-01
Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema) (NCT00269126)GlaxoSmithKline2005-02-01
Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study. (NCT00481182)GlaxoSmithKline2005-02-01
A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics (NCT00116883)GlaxoSmithKline2005-02-01
Post-Operative Nausea And Vomiting Study In Female Patients (NCT00274690)GlaxoSmithKline2005-02-01
Perennial Allergic Rhinitis Study In Pediatric Subjects (NCT00108914)GlaxoSmithKline2005-02-01
Drug Use Investigation for HEPSERA (Adefovir) Tablet (NCT01863589)GlaxoSmithKline2005-02-01
Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine (NCT00258700)GlaxoSmithKline2005-02-01
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP) (NCT00102739)GlaxoSmithKline2005-02-01
HuMax-CD20 in Active Rheumatoid Arthritis, Phase I/II (NCT00291928)GlaxoSmithKline2005-02-01
SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy (NCT00102726)GlaxoSmithKline2005-02-01
GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema) (NCT00269087)GlaxoSmithKline2005-01-28
Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics (NCT00364442)GlaxoSmithKline2005-01-28
Investigating The Pharmacokinetics Of An Inhaled Dose Of A New Corticosteroid In Patients With Impaired Liver Function (NCT00419237)GlaxoSmithKline2005-01-13
Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults (NCT00449436)GlaxoSmithKline2005-01-10
Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines (NCT00148941)GlaxoSmithKline2005-01-06
Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg) (NCT00358371)GlaxoSmithKline2005-01-06
Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths (NCT00158808)GlaxoSmithKline2005-01-01
The CLEVER Study - Coreg And Left Ventricular Mass Regression (NCT00108082)GlaxoSmithKline2005-01-01
Investigation Of A New Medication (GW642444) In Asthmatic Patients (NCT00354874)GlaxoSmithKline2005-01-01
Study on the Effects of an AMP Challenge on Asthmatic Patients Following Treatment With Fluticasone Propionate (NCT00400855)GlaxoSmithKline2005-01-01
Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes (NCT00116831)GlaxoSmithKline2005-01-01
Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma (NCT00256880)GlaxoSmithKline2005-01-01
A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults (NCT00116818)GlaxoSmithKline2005-01-01
Assess Safety & Reactogenicity of GSK Biologicals' Hib Vaccine Co-administered With or Without Chinese DTPw Vaccine (NCT00158795)GlaxoSmithKline2005-01-01
A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR). (NCT00103454)GlaxoSmithKline2005-01-01
A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS) (NCT00225862)GlaxoSmithKline2005-01-01
Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults (NCT01389479)GlaxoSmithKline2005-01-01
An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB) (NCT01205165)GlaxoSmithKline2004-12-17
Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy (NCT00104403)GlaxoSmithKline2004-12-01
Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients (NCT00300963)GlaxoSmithKline2004-12-01
Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia (NCT00593593)GlaxoSmithKline2004-12-01
Study In Adults And Adolescents With Seasonal Allergic Rhinitis (NCT00115622)GlaxoSmithKline2004-12-01
Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease (NCT00334568)GlaxoSmithKline2004-12-01
Study Of 323U66 SR In Major Depressive Disorder (NCT00135512)GlaxoSmithKline2004-12-01
Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia (NCT00103727)GlaxoSmithKline2004-12-01
AUGMENTIN 1gm In Skin And Soft Tissue Infection (NCT00343135)GlaxoSmithKline2004-12-01
An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And Inflammation (NCT00388180)GlaxoSmithKline2004-12-01
Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease Exacerbations (NCT00115492)GlaxoSmithKline2004-12-01
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer (NCT00097409)GlaxoSmithKline2004-12-01
Dental Pain (Following Third Molar Tooth Extraction) Study (NCT00114049)GlaxoSmithKline2004-12-01
AVODART(Dutasteride) Post-marketing Surveillance(PMS) (NCT01299571)GlaxoSmithKline2004-12-01
GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis (NCT00457171)GlaxoSmithKline2004-12-01
Special Drug Use Investigation for IMURAN (Azathioprine) Tablet (Pulmones Transplantation) (NCT01381432)GlaxoSmithKline2004-12-01
Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients (NCT00600990)GlaxoSmithKline2004-12-01
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures (NCT00104416)GlaxoSmithKline2004-12-01
Study With GW274150 In Patients With Mild Asthma (NCT00273013)GlaxoSmithKline2004-11-15
Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic Melanoma (NCT00107718)GlaxoSmithKline2004-11-15
Study In Asthma Control (NCT00273026)GlaxoSmithKline2004-11-08
Viapaed Study In Children And Adolescents With Asthma (NCT00315744)GlaxoSmithKline2004-11-04
Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants (NCT00325156)GlaxoSmithKline2004-11-02
LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures (NCT00144872)GlaxoSmithKline2004-11-01
Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults (NCT00289770)GlaxoSmithKline2004-11-01
Ispinesib In Combination With Capecitabine In Patients With Solid Tumors (NCT00119171)GlaxoSmithKline2004-11-01
Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease) (NCT00103922)GlaxoSmithKline2004-11-01
Fibromyalgia Study In Adults (NCT00256893)GlaxoSmithKline2004-11-01
Tucaresol As Add-On To HAART (Highly Active Antiretroviral Therapy) In Chronic HIV-1 Infected Adults (NCT00343941)GlaxoSmithKline2004-11-01
A Combination Therapy In Patients With Social Anxiety Disorder (NCT00403962)GlaxoSmithKline2004-11-01
Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects (NCT00323050)GlaxoSmithKline2004-11-01
The Anti-Inflammatory And Metabolic Effects Of Rosiglitazone In Subjects With Rheumatoid Arthritis (NCT00379600)GlaxoSmithKline2004-11-01
PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients (NCT00343707)GlaxoSmithKline2004-11-01
Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea (NCT00328965)GlaxoSmithKline2004-11-01
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule (NCT00289718)GlaxoSmithKline2004-11-01
← Previous Next →

Track GlaxoSmithKline automatically

Every clearance here is in the API, with alerts when new ones post.